Preview REPORT Cannabis Flowers in Germany 2021 - 2025

10 III List of Figures Figure 1: The path from producer to patient with the relevant stakeholders .............................11 Figure 2: Cannabis flowers as a mixture of active ingredients. ....................................................14 Figure 3: The entourage effect in cannabis therapy. ...................................................................15 Figure 4: THC plasma concentration after smoking and after oral intake. ...................................18 Figure 5: Legal framework for the cannabis market ....................................................................22 Figure 6: Pharmacy purchases of cannabis products. ..................................................................44 Figure 7: Development of cannabis flower suppliers in the German cannabis market 2028 to 2020..........................................................................................................................44 Figure 8: Development of the number of cannabis flowers on offer in the German cannabis market 2018 to 2020.....................................................................................................45 Figure 9: Germany map of top cannabis companies....................................................................46 Figure 10: Bedrocan cannabis flower share of total cannabis flower market. ...............................72 Figure 11: Pharmacy purchases of cannabis flower per quarter from 2018-Q1 to 2020-Q3. ........74 Figure 12: Cannabis prescriptions paid for by SHI funds 2018 to 2020..........................................76 Figure 13: Cannabis sales charged to SHI funds from 2018 to 2020. .............................................77 Figure 14: Prescriptions of cannabis flowers at the expense of the SHI from 2018-Q1 to 2020-Q3. .......................................................................................................................78 Figure 15: Cannabis flower sales charged to SHI from 2018-Q1 to 2020-Q3. ................................78 Figure 16: Trends in average tax values for cannabis flower prescriptions from 2018-Q1 to 2020-Q3. .......................................................................................................................79 Figure 17: Prescription shares of cannabis flower by specialist group 2018-Q1. ...........................80 Figure 18: Prescription shares of cannabis flower by specialist group 2020-Q3. ...........................80 Figure 19: Prescription shares by specialist group in the individual KVs in the third quarter of 2020 ..............................................................................................................................81 Figure 20: Prescription shares of cannabis flower by KVs between 2018-Q1 and 2020-Q3...........82 Figure 21: Prescription shares of cannabis flower by CTs per 1,000 population between 2019-10 and 2020-09. ...................................................................................................83 Figure 22: Average tax values by CTs for cannabis flower prescriptions between 2019-10 and 2020-09.........................................................................................................................84 Figure 23: Attitudes of political parties in Germany to the release of recreational use of cannabis ........................................................................................................................86 Figure 24: Trends in cannabis flower prescriptions between 2018-Q1 to 2020-Q3.......................87 Figure 25: Trends in cannabis flower prescriptions, projection to 2026, expansion versus stagnation. ....................................................................................................................88 Figure 26: Evolution of average tax values for cannabis flower prescriptions between 2018- Q1 and 2020-Q3............................................................................................................89 Figure 27: Development of sales for cannabis flower, projection until 2026.................................90